19 April 2024
Nykode Therapeutics Initiates Phase 2 Trial of VB10.16 in ...
Read More
The Nykode Therapeutics platform is built around the Vaccibody molecule. Inducing fast, strong and long-lasting immune responses, and demonstrating a positive safety profile, our pioneering Vaccibody™ vaccine has the potential to treat many disease areas, including cancer.